Publication | Open Access

Fractionated initial infusion and booster dose of ARI0002h, a humanised, BCMA-directed CAR T-cell therapy, for patients with relapsed or refractory multiple myeloma (CARTBCMA-HCB-01): a single-arm, multicentre, academic pilot study

Hematological MalignancyMedicineImmunologyHematologyInitial InfusionImmune Checkpoint InhibitorBooster DoseImmunotherapyOncologyRefractory Multiple Myeloma